阿尔茨海默病谱系脑代谢特征:[18F]FDG-PET在变异型AD诊断与预后中的价值
该回顾性研究纳入67例典型AD及变异型AD患者和11例随访后确诊为变异型AD的MCI受试者,采用W-score图在单个体水平评估[18F]FDG-PET脑低代谢模式,发现各变异型具有特定区域低代谢模式,ROC曲线显示高敏感性和特异性区分AD变异型及非AD痴呆,且前驱期已可检测并预测临床进展。
要点
- 典型AD与变异型AD各具特定脑低代谢模式,单个体水平一致性高。
- [18F]FDG-PET可高敏感性和特异性区分AD变异型与非AD痴呆。
- 前驱期MCI中已可检测变异型特异性低代谢模式并预测临床进展。
核心结论
- AD变异型特异性脑低代谢模式在单个体水平高度一致且前驱期已显现,是支持诊断和预测预后的重要神经退行性标志物。
研究设计与样本
- 回顾性研究,纳入N=67例按IWG-2标准诊断的典型AD及变异型AD患者(22例典型AD、15例额叶变异型AD、14例logopenic变异型AD、16例后部变异型AD),另纳入N=11例随访(21±11个月)后临床诊断为变异型AD痴呆的MCI受试者,采用W-score图在组水平和单个体水平评估脑低代谢模式及诊断准确性。
主要发现
- W-score图显示典型AD和各变异型AD具有 distinct 且特异性的低代谢模式,核心低代谢区域评估证实各变异型分别以枕叶、左侧或额叶脑区易损为特征。
- ROC曲线分析显示[18F]FDG-PET可区分AD变异型之间以及与非AD痴呆(如路易体痴呆和额颞叶痴呆行为变异型),具有高敏感性和特异性。
- 初步证据表明,在AD前驱期这些特异性[18F]FDG-PET模式已可检测,并预测随访时临床进展为相应变异型AD。
关键数值与推荐
- 诊断依据IWG-2标准;随访时间21±11个月;未报告具体敏感性、特异性数值及ROC曲线下面积。
临床怎么用
- 对于疑似变异型AD痴呆或MCI患者,[18F]FDG-PET脑低代谢模式可在单个体水平支持鉴别诊断,并辅助预测向特定变异型AD的临床进展。
局限性
- 回顾性设计;样本量有限(尤其MCI仅11例);未报告具体诊断准确性数值;需更大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Given the challenges posed by the clinical diagnosis of atypical Alzheimer's disease (AD) variants and the limited imaging evidence available in the prodromal phases of atypical AD, we assessed brain hypometabolism patterns at the single-subject level in the AD variants spectrum. Specifically, we tested the accuracy of [18F]FDG-PET brain hypometabolism, as a biomarker of neurodegeneration, in supporting the differential diagnosis of atypical AD variants in individuals with dementia and mild cognitive impairment (MCI). METHODS: We retrospectively collected N = 67 patients with a diagnosis of typical AD and AD variants according to the IWG-2 criteria (22 typical-AD, 15 frontal variant-AD, 14 logopenic variant-AD and 16 posterior variant-AD). Further, we included N = 11 MCI subjects, who subsequently received a clinical diagnosis of atypical AD dementia at follow-up (21 ± 11 months). We assessed brain hypometabolism patterns at group- and single-subject level, using W-score maps, measuring their accuracy in supporting differential diagnosis. In addition, the regional prevalence of cerebral hypometabolism was computed to identify the most vulnerable core regions. RESULTS: W-score maps pointed at distinct, specific patterns of hypometabolism in typical and atypical AD variants, confirmed by the assessment of core hypometabolism regions, showing that each variant was characterized by specific regional vulnerabilities, namely in occipital, left-sided, or frontal brain regions. ROC curves allowed discrimination among AD variants and also non-AD dementia (i.e., dementia with Lewy bodies and behavioral variant of frontotemporal dementia), with high sensitivity and specificity. Notably, we provide preliminary evidence that, even in AD prodromal phases, these specific [18F]FDG-PET patterns are already detectable and predictive of clinical progression to atypical AD variants at follow-up. CONCLUSIONS: The AD variant-specific patterns of brain hypometabolism, highly consistent at single-subject level and already evident in the prodromal stages, represent relevant markers of disease neurodegeneration, with highly supportive diagnostic and prognostic role.
引用
- Sala A, Caprioglio C, Santangelo R, et al. Brain metabolic signatures across the Alzheimer's disease spectrum. Eur J Nucl Med Mol Imaging. 2019. PMID: 31811345. doi:10.1007/s00259-019-04559-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。